JLABS
@JLABS
Followers
9K
Following
4K
Media
3K
Statuses
6K
A great idea can come from anywhere. JLABS is the global incubator network of @JNJNews. Community Guidelines: https://t.co/h28l0WZL55
Joined August 2011
Applying for membership or residency with JLABS can come with a lot of questions and variables. We've put together a helpful list of FAQs for innovators interested in working with us. Learn more here: https://t.co/bg44rxOj1l
0
0
0
JLABS Singapore has accomplished so much since it opened 2 years ago. From building a network of 50 current and alumni companies, to hosting entrepreneurs, investors, and leaders across J&J. Click here to read more on their mission: https://t.co/6BzELtRGH9
0
0
0
Before the year is out, be sure to subscribe to our Innovation newsletter, where you can meet some of our JLABS member and resident companies, learn more about their innovations, and stay updated on their progress in 2026! https://t.co/7ApCo22iEf
0
0
0
Join us in congratulating the awardee of the Korea Innovation QuickFire Challenge: Targeting Neuroscience. Orb Therapeutics will receive award funding, mentorship & more to help advance its idea to transform how neurological diseases are treated. https://t.co/3wzPsLbxHZ
0
0
3
In the last few months, our APAC team has participated in two major programs that highlight the strength of collaboration and scientific leadership across the region. Read more about them here: https://t.co/eK6VUkjoUN
0
0
1
The Data & AI Fueling R&D of Tomorrow QuickFire Challenge: Singapore & Beyond is live! Submit your novel data science & AI/ML tech with potential to transform how we discover new medicines for a chance at $400k in award funding, mentorship & more. https://t.co/QC0O5ltuiH
0
1
0
The deadline is approaching to submit your novel AI ideas aimed at transforming drug discovery & development using de novo designed antibody sequences against “hard-to-drug” targets. Apply by November 21: https://t.co/oM1XYWqncR
0
0
0
Applying for membership or residency with JLABS is a big step - and we know it. We want you to go into the process knowing all your options, the steps it takes, and how long the process lasts. Visit our apply page to learn more: https://t.co/KEgkH8KNi8
0
0
1
Imuno is working tirelessly to bring effective therapies to patients facing cancer or autoimmune diseases. They create antibodies against protein fragments found on diseased cells. Watch the video below to see how they're using JLABS to make it happen. https://t.co/vhMn5D0uqe
0
0
0
In-person or virtual - that is the question. We know the approach to innovation is not a one-size-fits-all, which is why we offer multiple options that fit your needs. Learn more about incubation with J&J here: https://t.co/bg44rxOj1l
0
0
0
Excited to see how innovators are tackling one of the biggest challenges in CAR-T therapy—vein-to-vein time. Looking forward to the event in Utrecht on 4 Dec!
Reducing vein-to-vein time in CAR-T therapy is critical for patient outcomes. Join us in Utrecht or virtually on 4 Dec to explore innovations in automation, analytics & next-gen gene therapy. Register here: https://t.co/5Igj2vlfpQ
0
0
1
Do you want your startup to stand out in immunology and inflammation? Don't miss these key takeaways.
J&J hosted a candid discussion in Amsterdam, revealing strategic insights on designing for superiority in immune restoration, tissue homeostasis, and multi-indication approaches. Get all the takeaways from Fiona MacLaughlin, investor at J&J! https://t.co/RFPwhB3Kw8
0
0
0
Across the globe, our JLABS residents & members are making a difference - from advances in oncology, to improving patient care, to making precision medicine more accessible. Stay up-to-date when you sign up for our Innovation newsletter today: https://t.co/Fb82vvoAdJ
0
0
0
The Pitching Critical Assessment for Therapeutic Protein Design (CAT-PD) QuickFire Challenge is open to apply! Submit your potentially transformative AI technologies aimed at designing antibody sequences against “hard-to-drug" targets. Deadline 11/21 https://t.co/oM1XYWqncR
0
0
0
Before you hit 'submit' on your JLABS application, make sure you review our strategic areas of focus, and our FAQ section - we want to make applying a thoughtful, straight-forward process. Visit our apply page here: https://t.co/KEgkH8KNi8
1
1
1
At our recent CEO roundtable, leaders from across the JLABS East North America community gathered with @ColumbiaCancer and @Columbia_Tech to build relationships, ask questions, and discuss new paths forward in cancer innovation. Read more here: https://t.co/EfP3GGAUmF
0
2
1
Joining the JLABS community isn't a one-size-fits-all approach. We offer multiple options because we know each start up's needs are different, and we want to do what we can to help. Whether that's virtually or in person. https://t.co/7NR6P1li0G
0
0
1
Medtech innovator Vivo Surgical is shaping the future of the OR by developing advanced surgical technology and robotics aimed at improving patient outcomes and addressing unmet medical needs. Learn more about the company and its mission here: https://t.co/NSYZ6HR6mL
0
1
0
Our global community is ready to help innovators like you push boundaries and usher in the next life-changing solutions in oncology, immunology, or neuroscience. Here's how you can apply for residency: https://t.co/pi1HuxuoRS
0
0
0